铁死会在喘中引发呼吸道炎症
Minming Li1,2, Min Li1, Yunjiao Hou1
1Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Therapeutic advances in respiratory disease
|November 10, 2023
概括
铁亡,细胞死亡过程,通过影响呼吸道细胞,有助于喘的发展. 铁灭抑制剂在改善喘症状方面表现有前途,并提供新的治疗途径.
科学领域:
- 细胞生物学 细胞生物学
- 病理生理学 病理生理学
- 肺部病理学 肺部病理学
背景情况:
- 铁亡是一种受调节的细胞死亡途径,涉及铁的积累和脂质过氧化,有助于氧化应激.
- 它与各种肺部疾病有关,包括急性肺损伤,COPD和肺纤维化.
- 新出现的证据将铁亡与喘的发病症联系起来.
研究的目的:
- 审查喘中铁亡的作用和机制.
- 描述铁和喘之间的关系,重点关注信号通路和调节因素.
- 总结了喘患者细胞中铁亡的观察结果.
主要方法:
- 对铁和喘研究的文献综述.
- 对调节铁亡的信号通路的分析 (铁,脂质,氨基酸代谢).
- 检查铁亡调节剂 (Nrf2,血红氧酶-1等) 的研究. 在喘病原体中.
- 在喘中进行细胞观察的综述 (乙素,呼吸道上皮细胞,光滑肌细胞).
主要成果:
- 铁,脂质和氨基酸代谢的干扰驱动呼吸道上皮细胞中的铁亡,恶化喘症状.
- 像Nrf2这样的关键铁亡调节体参与了喘的发展.
- 铁灭抑制剂已证明在改善喘方面具有有效性.
结论:
- 铁死在喘发病过程中起着重要作用.
- 了解铁灭的机制,可以了解喘的发展.
- 向铁亡提供了喘治疗的新治疗策略.
相关概念视频
Asthma: Pathogenesis and Management
420
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
420
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
310
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
310
Drugs Used in Lower Respiratory Disorders: Overview
455
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
455


